NCT05817734

Brief Summary

This is a prospective study aimed at recruiting 30,000 individuals, aged 40-70 years old, and following them longitudinally for 25 years with repeated measurements. The basic follow-up frame will include a visit to the Clinical Test Center (CTC) every two years and a phone interview every other year (on uneven years). Sample collection and biobanking will be performed every two years and online questionnaires will be filled out on an annual basis. The primary goals are to study the variation observed across different individuals in disease susceptibility, clinical phenotypes, and therapeutic responses. The study aims at studying the complex interplay and relative contribution of different omics, physiological characteristics and lifestyle on disease pathogenesis and progression and to evaluate how these effects are mediated.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30,000

participants targeted

Target at P75+ for all trials

Timeline
239mo left

Started Oct 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Oct 2018Dec 2045

Study Start

First participant enrolled

October 1, 2018

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
22.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2045

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2045

Last Updated

July 16, 2024

Status Verified

July 1, 2024

Enrollment Period

27.3 years

First QC Date

January 31, 2023

Last Update Submit

July 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adult disease

    Development of medical conditions based on participant's self-reporting coded to ICD11.

    25 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

General volunteering population who can freely register for the study.

You may qualify if:

  • Ages 18+, males and females.

You may not qualify if:

  • Pregnancy.
  • Mentally disabled or in general legally non-competent.
  • Prisoner or soldier. Soldiers: mandatory service only
  • Active cancer
  • Fertility Treatments (current)
  • Hepatitis ( B, C), chronic or acute
  • HIV
  • Liver cirrhosis
  • Dialysis
  • Unstable medical conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weizmann institute of science

Rehovot, Israel

RECRUITING

Related Publications (1)

  • Rein M, Elkan M, Godneva A, Dolev NC, Segal E. Sex-specific dietary habits and their association with weight change in healthy adults. BMC Med. 2024 Nov 6;22(1):512. doi: 10.1186/s12916-024-03730-3.

Biospecimen

Retention: SAMPLES WITH DNA

Blood and stool sampls

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Eran Segal, PI at the department of computer science and applied math

Study Record Dates

First Submitted

January 31, 2023

First Posted

April 18, 2023

Study Start

October 1, 2018

Primary Completion (Estimated)

December 31, 2045

Study Completion (Estimated)

December 31, 2045

Last Updated

July 16, 2024

Record last verified: 2024-07

Locations